Evan Loh Insider Trading $PRTK Paratek Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Evan Loh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Evan Loh. Evan Loh is Director in WINDTREE THERAPEUTICS INC /DE/ ($WINT) and CEO in Paratek Pharmaceuticals, Inc. ($PRTK) and President and CMO in Paratek Pharmaceuticals, Inc. ($PRTK) and President, COO and CMO in Paratek Pharmaceuticals, Inc. ($PRTK) and See Remarks in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Eiger BioPharmaceuticals, Inc. ($EIGR) and Director in Nivalis Therapeutics, Inc. ($NVLS).
Evan Loh in Paratek Pharmaceuticals, Inc.
Trading Symbol: PRTKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Evan Loh: CEO, President, COO and CMO, President and CMO, See Remarks
Holdings: 904,309 shares
Current Value: $13,790,712
Latest Transaction: Apr 01 2021
$PRTK Market Capitalization: $346.19M
$PRTK Previous Close: $15.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Evan Loh in Paratek Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, EIGR, PRTK, WINT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 303,750 | 0 | 904,309 | 600.6 K to 904.3 K (+50.58 %) |
Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 6.71 | 26,415 | 177,245 | 600,559 | 627 K to 600.6 K (-4.21 %) |
Dec 15 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 6.95 | 18,585 | 129,166 | 626,974 | 645.6 K to 627 K (-2.88 %) |
Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 5.93 | 20,928 | 124,103 | 645,559 | 666.5 K to 645.6 K (-3.14 %) |
Nov 16 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 75,000 | 0 | 666,487 | 591.5 K to 666.5 K (+12.68 %) |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Option Exercise | M | 4.30 | 39,479 | 169,760 | 0 | |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
Nov 02 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Buy | M | 4.30 | 39,479 | 169,760 | 591,487 | 552 K to 591.5 K (+7.15 %) |
May 14 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 4.75 | 9,595 | 45,576 | 552,008 | 561.6 K to 552 K (-1.71 %) |
Feb 21 2020 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 144,000 | 0 | 561,603 | 417.6 K to 561.6 K (+34.48 %) |
Dec 16 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.10 | 14,514 | 44,993 | 417,603 | 432.1 K to 417.6 K (-3.36 %) |
Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.82 | 7,818 | 29,865 | 432,117 | 439.9 K to 432.1 K (-1.78 %) |
Oct 08 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Grant | A | 0.00 | 26,000 | 0 | 439,935 | 413.9 K to 439.9 K (+6.28 %) |
Oct 07 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | CEO | Sell | S | 3.98 | 16,265 | 64,735 | 413,935 | 430.2 K to 413.9 K (-3.78 %) |
Feb 28 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 120,000 | 0 | 430,200 | 310.2 K to 430.2 K (+38.68 %) |
Feb 04 2019 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 32,500 | 0 | 310,200 | 277.7 K to 310.2 K (+11.70 %) |
Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 6.27 | 6,000 | 37,620 | 277,700 | 283.7 K to 277.7 K (-2.11 %) |
Dec 14 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 6.76 | 5,525 | 37,349 | 283,700 | 289.2 K to 283.7 K (-1.91 %) |
Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 8.96 | 5,200 | 46,592 | 289,225 | 294.4 K to 289.2 K (-1.77 %) |
Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 8.96 | 5,200 | 46,592 | 289,225 | 294.4 K to 289.2 K (-1.77 %) |
Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 294,425 | 281.4 K to 294.4 K (+4.62 %) |
Oct 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 294,425 | 281.4 K to 294.4 K (+4.62 %) |
Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 9.82 | 8,861 | 87,015 | 281,425 | 290.3 K to 281.4 K (-3.05 %) |
Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 55,000 | 0 | 290,286 | 235.3 K to 290.3 K (+23.38 %) |
Oct 04 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 32,500 | 0 | 235,286 | 202.8 K to 235.3 K (+16.03 %) |
Jul 05 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 9.97 | 12,000 | 119,640 | 202,786 | 214.8 K to 202.8 K (-5.59 %) |
Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 12.70 | 8,084 | 102,667 | 214,786 | 222.9 K to 214.8 K (-3.63 %) |
Apr 10 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 12.70 | 8,084 | 102,667 | 214,786 | 222.9 K to 214.8 K (-3.63 %) |
Apr 05 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 19,500 | 0 | 222,870 | 203.4 K to 222.9 K (+9.59 %) |
Feb 16 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 58,500 | 0 | 203,370 | 144.9 K to 203.4 K (+40.38 %) |
Feb 07 2018 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 14.22 | 3,040 | 43,229 | 144,870 | 147.9 K to 144.9 K (-2.06 %) |
Jul 21 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Option Exercise | M | 4.30 | 39,478 | 169,755 | 39,479 | |
Jul 21 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Buy | M | 4.30 | 39,478 | 169,755 | 147,910 | 108.4 K to 147.9 K (+36.41 %) |
Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 23.58 | 4,351 | 102,591 | 108,432 | 112.8 K to 108.4 K (-3.86 %) |
Jul 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Grant | A | 0.00 | 13,000 | 0 | 112,783 | 99.8 K to 112.8 K (+13.03 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.09 | 22 | 332 | 99,783 | 99.8 K to 99.8 K (-0.02 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.05 | 1,082 | 16,284 | 99,805 | 100.9 K to 99.8 K (-1.07 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.08 | 16 | 241 | 100,887 | 100.9 K to 100.9 K (-0.02 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.10 | 1,302 | 19,660 | 100,903 | 102.2 K to 100.9 K (-1.27 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.15 | 668 | 10,120 | 102,205 | 102.9 K to 102.2 K (-0.65 %) |
Feb 08 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Sell | S | 15.20 | 16 | 243 | 102,873 | 102.9 K to 102.9 K (-0.02 %) |
Feb 06 2017 | PRTK | Paratek Pharmaceut ... | Loh Evan | President, COO and ... | Option Exercise | A | 15.10 | 65,000 | 981,500 | 65,000 | |
Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | A | 14.05 | 45,000 | 632,250 | 45,000 | |
Feb 08 2016 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Grant | A | 0.00 | 22,500 | 0 | 102,889 | 80.4 K to 102.9 K (+27.99 %) |
Dec 14 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 16.67 | 900 | 15,003 | 80,389 | 79.5 K to 80.4 K (+1.13 %) |
Dec 14 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 17.00 | 1,400 | 23,800 | 79,489 | 78.1 K to 79.5 K (+1.79 %) |
Nov 18 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Buy | P | 16.16 | 3,700 | 59,792 | 78,089 | 74.4 K to 78.1 K (+4.97 %) |
Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | A | 25.77 | 60,000 | 1,546,200 | 60,000 | |
Jul 02 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Grant | A | 0.00 | 30,000 | 0 | 74,389 | 44.4 K to 74.4 K (+67.58 %) |
Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
Feb 06 2015 | PRTK | Paratek Pharmaceut ... | Loh Evan | President and CMO | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 236,871 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 157,914 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Option Exercise | J | 4.30 | 78,957 | 339,515 | 78,957 | |
Nov 03 2014 | PRTK | Paratek Pharmaceut ... | Loh Evan | See Remarks | Buy | J | 0.00 | 44,389 | 0 | 44,389 | 0 to 44.4 K |
Page: 1